Acute Spinal Cord Injury Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Acute Spinal Cord Injury Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The acute spinal cord injury market size has grown strongly in recent years. It will grow from $6.32 billion in 2023 to $6.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising incidence of acute spinal cord injuries, increasing awareness of acute spinal cord injury's and their treatment options, growing demand for personalized care, rising disposable income levels, increasing government spending on asci research and development.

The acute spinal cord injury market size is expected to see strong growth in the next few years. It will grow to $8.25 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to emerging therapies, telemedicine adoption, patient-centric care models, increasing focus on preventive healthcare and injury prevention. Major trends in the forecast period include medical advancements, rehabilitation techniques, neuroprotection therapies, psychosocial support, advocacy and accessibility.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12960&type=smp

Market Segmentation:
The main types of acute spinal cord injuries are complete spinal cord injury and incomplete spinal cord injury. Complete spinal cord injury refers to the total loss of sensory and motor function below the level of the spinal cord injury. The diagnosis types are laboratory tests and imaging tests applied in hospitals and clinics.
Acute Spinal Cord Injury Global Market Report 2023 provides data on the global acute spinal cord injury market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors' revenues, profiles and market shares. The acute spinal cord injury market report identifies opportunities and strategies based on market trends and leading competitors' approaches.

Major Driver - Rising Road Accidents Fuel Growth In The Acute Spinal Cord Injury Market
Increasing numbers of road accidents are expected to propel the acute spinal cord injury market going forward. A road accident refers to an incident involving the crashing of a motor vehicle that leads to wounding or severe fatality. Accidental spinal injuries can harm the central nervous system (CNS) and disrupt the passage of nerves required for function and sensory skills. The strength of an accident's impact can cause trauma to the cervical, lumbar, or thoracic spine, damaging or severing the spinal cord and causing paralysis. For instance, in August 2022, according to the National Highway Traffic Safety Administration, a US-based government agency, 9,560 individuals died in traffic accidents in the first quarter of 2022, an increase of 7% compared to the 8,935 fatalities for the same period in 2021. Therefore, an increase in road accidents drives the growth of the acute spinal cord injury market.

Competitive Landscape:
Major players in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Top Trend - Innovation In Precision Treatment For Unique Medical Needs
Major companies operating in the acute spinal cord injury market are focusing on developing innovative drugs to treat their customers and sustain their position in the market. The development of new drugs such as, LYVISPAH can improve treatment outcomes for patients with using combination therapy. For instance, in July 2022, Amneal Pharmaceuticals, a US-based pharmaceutical company, launched LYVISPAH, a baclofen oral granule (5, 10 and 20 mg) approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity that is related to multiple sclerosis and other spinal cord disorders. LYVISPAH treats and relieves flexor spasms and associated pain, clones and muscular rigidity. It provides flexible, tailored dosage with single-dose packages of granules in doses of 5 mg, 10 mg and 20 mg and is bioequivalent to oral baclofen tablets. Patients with spinal cord injuries and other spinal cord diseases may also benefit from using LYVISPAH.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Acute Spinal Cord Injury Market Characteristics
3. Acute Spinal Cord Injury Market Trends And Strategies
4. Acute Spinal Cord Injury Market - Macro Economic Scenario
5. Acute Spinal Cord Injury Market Size And Growth
…..
27. Acute Spinal Cord Injury Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.